G

Genincode PLC
LSE:GENI

Watchlist Manager
Genincode PLC
LSE:GENI
Watchlist
Price: 1.2 GBX 11.63% Market Closed
Market Cap: £9m

Genincode PLC
Investor Relations

GENinCode UK Ltd. engages in the risk assessment and prediction of cardiovascular disease. The company is headquartered in Oxford, Oxfordshire. The company went IPO on 2021-07-22. The firm develops patented deoxyribonucleic acid (DNA) risk assessment products which utilize artificial intelligence (AI), bioinformatics and a globally recognized clinical evidence base to provide predictive analysis of a patient’s health risk. The Company’s clinical diagnostic tests cover global disease areas such as cardiovascular, cancer and diabetes.

Show more
Loading
GENI
FTSE All Share Index
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q2 2025
Call Date
Oct 2, 2025
Q2 2025 Earnings Call
No Analysis Available

This earnings call has not been analyzed yet.

If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.

Request Earnings Call Analysis
Other Earnings Calls
2025

Management

Mr. Matthew Heaton Walls
Co-Founder, CEO & Director
No Bio Available
Mr. Jordi Puig Gilberte
Co-Founder, COO & Director
No Bio Available
Mr. Paul Andrew Peter Foulger
CFO, Company Secretary & Director
No Bio Available

Contacts

Address
OXFORDSHIRE
Oxford
Oxford Science Park, John Eccles House, Robert Robertson Avenue
Contacts
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett